UBS AM’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
UBS AM's NVCT Position: Q3 2026 in Review
UBS AM opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 92 shares worth $1.94K. The stake represents ﹤0.01% of the portfolio and ranks #4049 among its holdings.
76 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.
- UBS AM held 92 shares of Nuvectis Pharma worth $1.94K as of Q3 2026.
- Nuvectis Pharma was a new UBS AM position in Q3 2026.
- Nuvectis Pharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4049 holding.
- 76 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.